About 5,960,000 results
Navitoclax - Wikipedia
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven ...
Navitoclax (ABT-263) | ≥99%(HPLC) | Selleck | Bcl-2 阻害剤
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Targeting anti-apoptotic pathways eliminates senescent ...
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for ...
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti ...
ABT-263 induces G1/G0-phase arrest, apoptosis and ...
ABT-263 Reduces Hypertrophic Scars by Targeting Apoptosis ...